Interleukin-6 and statin therapy: potential role in the management of COPD

por Young, Robert P, Hopkins, Raewyn J
Publicado 2013

A review of the Hispanic paradox: time to spill the beans?

por Young, Robert P., Hopkins, Raewyn J.
Publicado 2014

GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?

por Young, Robert P, Hopkins, Raewyn J, Hay, Bryan A, Gamble, Gregory D
Publicado 2011

Genetic evidence linking lung cancer and COPD: a new perspective

por Young, Robert P, Hopkins, Raewyn J, Gamble, Gregory D, Etzel, Carol, El-Zein, Randa, Crapo, James D
Publicado 2011

Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD

por Young, Robert P., Hopkins, Raewyn J., Whittington, Chris F., Hay, Bryan A., Epton, Michael J., Gamble, Gregory D.
Publicado 2011

FAM13A locus in COPD is independently associated with lung cancer – evidence of a molecular genetic link between COPD and lung cancer

por Young, Robert P, Hopkins, Raewyn J, Hay, Bryan A, Whittington, Chris F, Epton, Michael J, Gamble, Gregory D
Publicado 2010

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model

por MARCUS, MICHAEL W., RAJI, OLAIDE Y., DUFFY, STEPHEN W., YOUNG, ROBERT P., HOPKINS, RAEWYN J., FIELD, JOHN K.
Publicado 2016

Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants

por Young, Robert P., Hopkins, Raewyn J., Hay, Bryan A., Epton, Michael J., Mills, Graham D., Black, Peter N., Gardner, Heather D., Sullivan, Richard, Gamble, Gregory D.
Publicado 2009